Literature DB >> 17504299

E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours.

Augusto José Ferreira De Matos1, Célia Cristina Carreiras Lopes, Augusto Manuel Rodrigues Faustino, Júlio Gil Vale Carvalheira, Gerard Roel Rutteman, Maria De Fátima Rodrigues Moutinho Gärtner.   

Abstract

Recent studies of canine malignant mammary tumours suggest that reduction of E-cadherin and/or beta-catenin correlates with invasive behaviour and lymph node metastasis. The aims of this study were to examine the interrelationships between the expression of E-cadherin and beta-catenin, and the relationship between the expression of E-cadherin and/or beta-catenin and the mode of growth and metastatic capacity of canine malignant mammary tumours. 90 spontaneous malignant tumours and local and regional lymph nodes were studied. A significant relationship was evidenced between membranous expression of E-cadherin and beta-catenin (p=0.0027), but not between E-cadherin and cytoplasmic beta-catenin. Only E-cadherin as a separate factor was significantly related to tumour invasion (p=0.0072) and lymph node metastasis (p=0.0001). Neither membranous nor cytoplasmic beta-catenin expression was significantly related to either of these phenomena.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17504299     DOI: 10.1111/j.1600-0463.2007.apm_544.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  8 in total

1.  Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification.

Authors:  A Gama; A Alves; F Schmitt
Journal:  Virchows Arch       Date:  2008-08-02       Impact factor: 4.064

2.  Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles.

Authors:  Robert Klopfleisch; Dido Lenze; Michael Hummel; Achim D Gruber
Journal:  BMC Cancer       Date:  2010-11-09       Impact factor: 4.430

3.  Cadherin cell adhesion system in canine mammary cancer: a review.

Authors:  Adelina Gama; Fernando Schmitt
Journal:  Vet Med Int       Date:  2012-08-22

4.  Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.

Authors:  Michèle Spoerri; Franco Guscetti; Sonja Hartnack; Alois Boos; Christine Oei; Orsolya Balogh; Renata M Nowaczyk; Erika Michel; Iris M Reichler; Mariusz P Kowalewski
Journal:  BMC Vet Res       Date:  2015-09-15       Impact factor: 2.741

5.  Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas.

Authors:  Ana Catarina Figueira; Catarina Gomes; Joana Tavares de Oliveira; Hugo Vilhena; Júlio Carvalheira; Augusto J F de Matos; Patrícia Dias Pereira; Fátima Gärtner
Journal:  BMC Vet Res       Date:  2014-11-26       Impact factor: 2.741

Review 6.  Molecular Signaling of Progesterone, Growth Hormone, Wnt, and HER in Mammary Glands of Dogs, Rodents, and Humans: New Treatment Target Identification.

Authors:  Elpetra P M Timmermans-Sprang; Ana Gracanin; Jan A Mol
Journal:  Front Vet Sci       Date:  2017-04-13

Review 7.  Role of Cadherins in Cancer-A Review.

Authors:  Ilona Kaszak; Olga Witkowska-Piłaszewicz; Zuzanna Niewiadomska; Bożena Dworecka-Kaszak; Felix Ngosa Toka; Piotr Jurka
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

8.  Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expression.

Authors:  Ana Gracanin; Elpetra P M Timmermans-Sprang; Monique E van Wolferen; Nagesha A S Rao; Juraj Grizelj; Silvijo Vince; Eva Hellmen; Jan A Mol
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.